Association between prescribing patterns of anti-asthmatic drugs and clinically uncontrolled asthma: A cross-sectional study

Pulmonary Pharmacology and Therapeutics

Volumn 24, Issue 6, 2011, Pages 647-653

  Davidsen, Jesper Rømhild ^a,b   Hallas, Jesper ^a   Søndergaard, Jens ^a   Christensen, René dePont ^a   Siersted, Hans Christian ^b   Hansen, Malene Plejdrup ^a   Knudsen, Thomas Bøllingtoft ^a   Lykkegaard, Jesper ^a   Andersen, Morten ^a,c  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^b ODENSE UNIVERSITY HOSPITAL   (Denmark)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

ACQ; Asthma control; Cross sectional study; Pharmacoepidemiology; Short acting beta 2 agonists; Treatment

Indexed keywords

ANTIASTHMATIC AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; GLUCOCORTICOID; LEUKOTRIENE RECEPTOR BLOCKING AGENT; LONG ACTING DRUG; METHYLXANTHINE DERIVATIVE; SHORT ACTING DRUG;

ADULT; AGE DISTRIBUTION; ARTICLE; ASTHMA; CLINICAL ASSESSMENT; CORTICOSTEROID THERAPY; DISEASE ASSOCIATION; DRUG USE; FEMALE; GENDER; HUMAN; MAJOR CLINICAL STUDY; MALE; PHARMACOEPIDEMIOLOGY; PRESCRIPTION; PRIORITY JOURNAL; QUESTIONNAIRE; SPIROMETRY; STATISTICAL ANALYSIS;

ADOLESCENT; ADRENERGIC BETA-2 RECEPTOR AGONISTS; ADULT; ANTI-ASTHMATIC AGENTS; ASTHMA; CROSS-SECTIONAL STUDIES; DRUG UTILIZATION; FEMALE; HUMANS; LOGISTIC MODELS; MALE;

EID: 80955149007     PISSN: 10945539     EISSN: 15229629     Source Type: Journal    
DOI: 10.1016/j.pupt.2011.09.001     Document Type: Article

References (33)

1. Hoven J.L., Haaijer-Ruskamp F.M., Vander Stichele R.H. Indicators of prescribing quality in drug utilisation research: report of a European meeting (DURQUIM, 13-15 May 2004. Eur J Clin Pharmacol 2005, 60:831-834.
2. Martirosyan L., Arah O.A., Haaijer-Ruskamp F.M., Braspenning J., Denig P. Methods to identify the target population: implications for prescribing quality indicators. BMC Health Serv Res 2010, 10:137.
3. Hallas J., Hansen N.C. Individual utilization of anti-asthma medication by young adults: a prescription database analysis. J Intern Med 1993, 234:65-70.
4. Gaist D., Hallas J., Hansen N.C., Gram L.F. Are young adults with asthma treated sufficiently with inhaled steroids? a population-based study of prescription data from 1991 and 1994. Br J Clin Pharmacol 1996, 41:285-289.
5. Klomp H., Lawson J.A., Cockcroft D.W., Chan B.T., Cascagnette P., Gander L., et al. Examining asthma quality of care using a population-based approach. CMAJ 2008, 8(178):1013-1021.
6. Davidsen J.R., Søndergaard J., Hallas J., Siersted H.C., Lykkegaard J., Andersen M. Increased use of inhaled corticosteroids among young Danish adult asthmatics: an observational study. Respir Med 2010, 104:1817-1824.
7. Himmel W., Hummers-Pradier E., Schumann H., Kochen M.M. The predictive value of asthma medications to identify individuals with asthma-a study in German general practices. Br J Gen Pract 2001, 51:879-883.
8. Pont L.G., Denig P., van der Molen T., van der Veen J.V., Haaijer-Ruskamp F.M. Validity of performance indicators for assessing prescribing quality: the case of asthma. Eur J Clin Pharmacol 2004, 59:833-840.
9. Andersen M. Is it possible to measure prescribing quality using only prescription data?. Basic Clin Pharmacol Toxicol 2006, 98:314-319.
10. Global Initiative for Asthma (GINA) Global strategy for asthma management and prevention 2009, GINA, Available from:, [accessed 01.08.11]. http://www.ginasthma.org.
11. National Asthma Education and Prevention Programme Expert panel report 3: guidelines for the diagnosis and management of asthma August 2007, National Heart, Lung and Blood Institute, Bethesda MD, Full Report 2007. NIH Publication No. 07-4051. Available from:, [accessed 01.08.11]. http://www.nhlbi.nih.gov/guidelines/asthma/asthgdln.pdf.
12. Partridge M.R., van der M.T., Myrseth S.E., Busse W.W. Attitudes and actions of asthma patients on regular maintenance therapy: the INSPIRE study. BMC Pulm Med 2006, 6:13.
13. Kaplan A., Ryan D. The role of budesonide/formoterol for maintenance and relief in the management of asthma. Pulm Pharmacol Ther 2010, 23:88-96.
14. Statistics Denmark. Available at: [accessed 01.08.11]. http://www.dst.dk.
15. Hallas J., Dall M., Andries A., Andersen B.S., Aalykke C., Hansen J.M., et al. Use of single and combined antithrombotic therapy and risk of serious upper gastrointestinal bleeding: population based case-control study. BMJ 2006, 333:726.
16. WHO Collaborating Centre for Drug Statistics Methodology ATC index with DDDs and guidelines for ATC classification and DDD assignment 2006, Norwegian Institute of Public Health, Oslo.
17. Gaist D., Sorensen H.T., Hallas J. The Danish prescription registries. Dan Med Bull 1997, 44:445-448.
18. Juniper E.F., O'Byrne P.M., Guyatt G.H., Ferrie P.J., King D.R. Development and validation of a questionnaire to measure asthma control. Eur Respir J 1999, 14:902-907.
19. Juniper E.F., Bousquet J., Abetz L., Bateman E.D. Identifying 'well-controlled' and 'not well-controlled' asthma using the asthma control questionnaire. Respir Med 2006, 100:616-621.
20. Davidsen J.R., Søndergaard J., Hallas J., Siersted H.C., Knudsen T.B., Lykkegaard J., et al. Impact of socioeconomic status on the use of inhaled corticosteroids in young adult asthmatics. Respir Med 2011, 105:683-690.
21. Miller M.R., Hankinson J., Brusasco V., Burgos F., Casaburi R., Coates A., et al. Standardisation of spirometry. Eur Respir J 2005, 26:319-338.
22. Fanta C.H. Asthma N Engl J Med 2009, 5(360):1002-1014.
23. Lynd L.D., Guh D.P., Pare P.D., Anis A.H. Patterns of inhaled asthma medication use: a 3-year longitudinal analysis of prescription claims data from British Columbia, Canada. Chest 2002, 122:1973-1981.
24. Laforest L., Van G.E., Devouassoux G., Bousquet J., Chretin S., Bauguil G., et al. Influence of patients' characteristics and disease management on asthma control. J Allergy Clin Immunol 2006, 117:1404-1410.
25. Pont L.G., van der Werf G.T., Denig P., Haaijer-Ruskamp F.M. Identifying general practice patients diagnosed with asthma and their exacerbation episodes from prescribing data. Eur J Clin Pharmacol 2002, 57:819-825.
26. Moth G., Vedsted P., Schiotz P. Identification of asthmatic children using prescription data and diagnosis. Eur J Clin Pharmacol 2007, 63:605-611.
27. Toren K., Brisman J., Jarvholm B. Asthma and asthma-like symptoms in adults assessed by questionnaires. A literature review. Chest 1993, 104:600-608.
28. Thomsen S.F., Ulrik C.S., Kyvik K.O., Larsen K., Skadhauge L.R., Steffensen I., et al. The incidence of asthma in young adults. Chest 2005, 127:1928-1934.
29. Juniper E.F., Svensson K., Mork A.C., Stahl E. Measurement properties and interpretation of three shortened versions of the asthma control questionnaire. Respir Med 2005, 99:553-558.
30. Ronmark E., Lundqvist A., Lundback B., Nystrom L. Non-responders to a postal questionnaire on respiratory symptoms and diseases. Eur J Epidemiol 1999, 15:293-299.
31. Fuhlbrigge A.L. Asthma severity and asthma control: symptoms, pulmonary function, and inflammatory markers. Curr Opin Pulm Med 2004, 10:1-6.
32. Rothman K.J., Greenland S., Lash T.L. Modern epidemiology 2008, Lippincott Williams & Wilkins, Philadelphia. 3rd ed.
33. Danish Medicines Agency. Available at: [accessed 01.08.11]. http://www.medstat.dk/.